Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-01-26
2011-11-15
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S093600, C424S185100, C424S206100, C424S281100, C435S070100, C435S235100
Reexamination Certificate
active
08057806
ABSTRACT:
A method to prepare viruses lacking ion channel activity is provided.
REFERENCES:
patent: 5994526 (1999-11-01), Meulewaeter et al.
patent: 6194546 (2001-02-01), Newton et al.
patent: 6872395 (2005-03-01), Kawaoka
patent: 7588769 (2009-09-01), Kawaoka
patent: 2004/0063141 (2004-04-01), Lok
patent: 2006/0246092 (2006-11-01), Neirynck et al.
patent: 2007/0231348 (2007-10-01), Kawaoka et al.
patent: 2010/0247572 (2010-09-01), Kawaoka
patent: WO-96/10632 (1996-04-01), None
patent: WO-96/40955 (1996-12-01), None
patent: WO-00/53786 (2000-09-01), None
patent: WO-01/79273 (2001-10-01), None
patent: WO-0179273 (2001-10-01), None
patent: WO-2004/094466 (2004-11-01), None
Fodor et al., Rescue of Influenza A Virus from Recombinant DNA, 1999, Journal of Virology, vol. 73, No. 11, pp. 9679-9682.
Watanabe et al., Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine, 2009, Journal of Virology, vol. 83, No. 11, pp. 5947-5950.
Bowie et al., Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions, 1990, Science, vol. 247, No. 4948, pp. 1306-1310.
Castrucci, Maria R., et al., “Reverse Genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-Terminal residue of M2 protein”,J. of Virology, vol. 69, No. 5, XP002196651, (May 1995),2725-2728.
Duff, K. C., et al., “The secondary structure of influenza A M2 transmembrane domain”,FEBS Letters, 311 (3), (Oct. 1992),pp. 256-258.
Duff, K. C., et al., “The Transmembrane Domain of Influenza A M2 Protein Forms Amantadine-Sensitive Proton Channels in Planar Lipid Bilayers”,Vilology, 190(1), (Sep. 1992),pp. 485-489.
Grambas, S. , et al., “Influence of Amantadine Resistance Mutations on the pH Regulatory Function of the M2 Protein of Influenza A Viruses”,Virology, 191 (2), (Dec. 1992),pp. 541-549.
Hay, A. J., et al., “The role of the M2 protein in influenza A virus infection”,Proceedings of the International Conference on Options for the Control of Influenza, Courchevel,(1992),pp. 281-288.
Helenius, A. , “Unpacking the Incoming Influenza Virus”,Cell. 69, (May 1992),pp. 577-578.
Holsinger, L. J., et al., “Influenza A Virus M2 Ion Channel Protein: a Structure-Function Analysis”,Journal of Virology, 68 (3), (1994),pp. 1551-1563.
Mena, Ignacio , et al., “Rescue of a Synthetic Choramphenicol Acetyltransferase RNA into influenza Virus-Like Particles obtained from recombinant plasmids”,J. of Virology, vol. 70, No. 8, XP002150091, (Aug. 1996),5016-5024.
Neirynck, S. , “A universal influenza A vaccine based on the extracellular domain of the M2 protein”,Nature Medicine, 5 (10), (Oct. 1999),pp. 1157-1163.
Neumann, Gabrielle, et al., “Generation of influenza A viruses entirely from cloned cDNAs”,Proc. of the Nat'l Academy of Sciences, vol. 96, XP002150093, (Aug. 1999),9345-9350.
Neumann, Gabriele , et al., “Plasmid-Driven Formation of Influenza Virus-Like Particles”,J. of Virology, vol. 74, No. 1, XP002150094, (Jan. 2000),547-551.
Neumann, Gabriele , et al., “Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell Culture”, Journal of Virology 76 (1), (Jan. 2002),406-410.
Neuman, Gabriele , et al., “RNA Polymerase I-Mediated Expression of Influenza Viral RNA Molecules”,Virology, vol. 202, No. 1, XP000952667, (Jul. 1994),477-479.
Park, Eun K., et al., “The M2 Ectodomain is important for its incorporation into influenza A virions”,J. of Virology, vol. 72, No. 3, XP002196797, (Mar. 1998),2449-2455.
Pekosz, A., et al., “Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence”,PNAS, vol. 95, XP002196653, (Oct. 1998),13233-13238.
Piller, S C., et al., “Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers”,PNAS, 93, (1996),111-1115.
Pinto, L. H., et al., “Influenza Virus M2 Protein Has Ion Channel Activity”,Cell, 69, (May 1992),pp. 517-528.
Pleschka, Stephan , et al., “A Plasmid-Based Reverse Gentics System for Influenza A Virus”,J. of Virology, vol. 70, No. 6, XP002150092, (Jun. 1996),4188-4192.
Sansom, M. S., et al., “Influenza virus M2 Protein: a molecular modelling study of the ion channel”,Protein Engineering, 6(1), (1993),pp. 65-74.
Skehel, J. J., et al., “On the Mechanism of Inhibition of Influenza Virus Replication by Amantadine Hydrochloride”,The Journal of General Virology, 38 (1), (1977),pp. 97-110.
Sugrue, R. J., et al., “Specific structural alteration of the influenza haemagglutinin by amantadine”,The EMBO Journal, 9 (11), (1990),pp. 3469-3476.
Sugrue, R. J., et al., “Structural Characteristics of the M2 Protein of Influenza A Viruses: Evidence That It Forms a Tetrameric Channel”,Virology, 180, (1991),pp. 617-624.
Sunstrom, N. A., et al., “Ion Channels formed by NB, an influenza B virus Protein”,J. of Membrane Biology, vol. 150, XP002196654, (Dec. 1996),127-132.
Sweet, T. M., et al., “Creation of Amantadine resistant clones of influenza type A virus using a new transfection procedure”,J of Virological Methods, vol. 69, XP002196650, (1997),103-111.
Takeuchi, K. , et al., “Influenza Virus M2 Protein Ion Channel Activity Stabilizes the Native Form of Fowl Plague Virus Hemagglutinin during Intracellular Transport”,Journal of Virology, 68 (2), (Feb. 1994),pp. 911-919.
Volchkov, Viktor E., et al., “Recovery of Infectious Ebola Virus from Complementary DNA: RNA Editing of the GP Gene and Viral Cytotoxicity”,Science Magazine, 291, (Mar. 2001),1965-1969.
Wang, C. , et al., “Ion Channel Activity of Influenza A Virus M2 Protein: Characterization of the Amantadine Block”,Journal of Virology, 67 (9), (Sep. 1993),pp. 5585-5594.
“Canadian Patent Application Serial No. 2,406,180, Response filed Jan. 26, 2009 to Official Action mailed Sep. 9, 2008”, 22 pgs.
“European Application Serial No. 04750333.9, Office Action mailed Jan. 22, 2009”, 5 pgs.
“European Application Serial No. 04750333.9, Response filed Oct. 21, 2008 to Communication mailed Apr. 11, 2008”, 15 pgs.
“International Application Serial No. PCT/US01/11963, Amendment and Response filed Sep. 9, 2002 to Written Opinion mailed Aug. 7, 2002”, 12 pgs.
“International Application Serial No. PCT/US2004/012050, International Search Report mailed Feb. 2, 2005”, 8 pgs.
“International Application Serial No. PCT/US01/11963, International Preliminary Examination Report mailed Oct. 15, 2002”, 13 pgs.
“Israel Application Serial No. 171372, Office Action Mailed Nov. 6, 2008”, 12 pgs.
“Korean Patent Application No. 10-2005-7020077, Examination Report mailed Dec. 28, 2007”, 5 pgs.
“Korean Patent Application No. 10-2005-7020077, Notice of Preliminary Rejection mailed Jun. 28, 2007”, (w/ EnglishTranslation),9 pgs.
“Korean Patent Application No. 10-2005-7020077, Response filed Apr. 28, 2008 to Examination Report mailed Dec. 28, 2007”, (w/ English Translation),41 pgs.
“Korean Patent Application No. 10-2005-7020077, Response filed Aug. 28, 2007 to Notice of Preliminary Rejection mailed Jun. 28, 2007”, (w/ EnglishTranslation),40 pgs.
“Russian Federation Application No. 2005136233, Office Action mailed Dec. 25, 2007”, 2 pgs.
“Russian Federation Application No. 2005136233, Response filed May 29, 2008 to Office Action mailed Dec. 25, 2007”, 7 pgs.
Bourmakina, S. V., et al., “Reverse genetics studies on the Filamentous morphology of influenza A Virus”,Journal of General Virology(2003) 84,517-527.
“1.A.32 The Type B Influenza Virus NB Channel (NB-C) Family”,Transport Protein Database, (U
Blumel Benjamin P
Mosher Mary E
Schwegman Lundberg & Woessner, P.A.
Wisconsin Alumni Research Foundation
LandOfFree
Viruses comprising mutant ion channel protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viruses comprising mutant ion channel protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viruses comprising mutant ion channel protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4311140